Tetrahydrofuran

Tetrahydrofuran

SCHEMBL6350216

C1CCOC1.CCOc1ccccc1-c1ccc2c(c1)C=C(C(=O)Nc1ccc(CN(C)C3CCOCC3)cc1)CCN2CC

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 5/20 0.54
CCR5 P51681 13/20 0.51
CXCR3 P49682 3/20 0.41
CXCR5 P32302 1/20 0.41
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
MCL1 Q07820 1/20 0.39
MCHR1 Q99705 1/20 0.39
CCR7 P32248 2/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrahydrofuran SCHEMBL6345290 0.94 CCR2 (0.52) CCR2CCR5CXCR3CXCR5MCHR1
Tetrahydrofuran SCHEMBL6341918 0.94 CCR2 (0.52) CCR2CCR5CXCR3CXCR5MCHR1
Tetrahydrofuran SCHEMBL6341763 0.94 CCR2 (0.52) CCR2CCR5CXCR3CXCR5MCHR1
Tetrahydrofuran SCHEMBL6344188 0.93 CCR2 (0.51) CCR2CCR5CXCR3CXCR5MCHR1
Tetrahydrofuran SCHEMBL6342705 0.92 CCR2 (0.50) CCR2CCR5CXCR3CXCR5MEN1
Tetrahydrofuran SCHEMBL6342680 0.92 CCR2 (0.50) CCR2CCR5CXCR3CXCR5MEN1
Tetrahydrofuran SCHEMBL6344937 0.91 CCR2 (0.52) CCR2CCR5CXCR3CXCR5MCHR1
Tetrahydrofuran SCHEMBL6341366 0.91 CCR2 (0.52) CCR2CCR5CXCR3CXCR5MCHR1
Tetrahydrofuran SCHEMBL6341979 0.91 CCR2 (0.49) CCR2CCR5CXCR3CXCR5MCHR1
Tetrahydrofuran SCHEMBL6342637 0.91 CCR2 (0.49) CCR2CCR5CXCR3CXCR5MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936602-B1 Benzazepine derivatives, process for the preparation of the same and uses thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-08-30 US claimed
EP-1186604-A1 BENZAZEPINE DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-03-13 EP claimed
US-6936602-B1 Benzazepine derivatives, process for the preparation of the same and uses thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-08-30 US disclosed
US-20030078189-A1 Medicinal compositions for oral use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-04-24 US disclosed
EP-1186604-A1 BENZAZEPINE DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078189-A1 Medicinal compositions for oral use CCR5, CXCR3, CCL5 CCR2 23/4885CCR5 1/4885CXCR3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.